OBJECTIVE: The authors described clinical presentations of oral and genital herpes simplex virus (HSV) infections in a university health population and implications of these findings. PARTICIPANTS AND METHODS: Using a standardized data collection tool, 215 records of patients with symptomatic culture-positive HSV infections were reviewed. RESULTS: HSV-1 accounted for 78% of female and 85% of male genital herpes (GH) infections, and oral herpes (OH) infections presented as an acute febrile illness (AFI) in 51% of those 18 to 24 years old. HSV-2 accounted for 68% of GH infections among adults 25 or older. CONCLUSIONS: As seroprevalence for both HSV-1 and HSV-2 in the United States is decreasing, a growing college age cohort is at risk for primary HSV-1 infection. The proportion of GH caused by HSV-1 also continues to increase. This understanding has implications for clinical care, sexual health programming, and counseling strategies.
OBJECTIVE: The authors described clinical presentations of oral and genital herpes simplex virus (HSV) infections in a university health population and implications of these findings. PARTICIPANTS AND METHODS: Using a standardized data collection tool, 215 records of patients with symptomatic culture-positive HSV infections were reviewed. RESULTS:HSV-1 accounted for 78% of female and 85% of male genital herpes (GH) infections, and oral herpes (OH) infections presented as an acute febrile illness (AFI) in 51% of those 18 to 24 years old. HSV-2 accounted for 68% of GH infections among adults 25 or older. CONCLUSIONS: As seroprevalence for both HSV-1 and HSV-2 in the United States is decreasing, a growing college age cohort is at risk for primary HSV-1 infection. The proportion of GH caused by HSV-1 also continues to increase. This understanding has implications for clinical care, sexual health programming, and counseling strategies.
Authors: John E Tavis; Hong Wang; Ann E Tollefson; Baoling Ying; Maria Korom; Xiaohong Cheng; Feng Cao; Katie L Davis; William S M Wold; Lynda A Morrison Journal: Antimicrob Agents Chemother Date: 2014-09-29 Impact factor: 5.191
Authors: Peter J Ireland; John E Tavis; Michael P D'Erasmo; Danielle R Hirsch; Ryan P Murelli; Mark M Cadiz; Bindi S Patel; Ankit K Gupta; Tiffany C Edwards; Maria Korom; Eileen A Moran; Lynda A Morrison Journal: Antimicrob Agents Chemother Date: 2016-03-25 Impact factor: 5.191
Authors: Christopher Petro; Pablo A González; Natalia Cheshenko; Thomas Jandl; Nazanin Khajoueinejad; Angèle Bénard; Mayami Sengupta; Betsy C Herold; William R Jacobs Journal: Elife Date: 2015-03-10 Impact factor: 8.140
Authors: Raquel Bello-Morales; Beatriz Praena; Carmen de la Nuez; María Teresa Rejas; Milagros Guerra; Marcos Galán-Ganga; Manuel Izquierdo; Víctor Calvo; Claude Krummenacher; José Antonio López-Guerrero Journal: J Virol Date: 2018-04-27 Impact factor: 5.103
Authors: Paula A Suazo; Francisco J Ibañez; Angello R Retamal-Díaz; Marysol V Paz-Fiblas; Susan M Bueno; Alexis M Kalergis; Pablo A González Journal: Mediators Inflamm Date: 2015-03-30 Impact factor: 4.711